404
+1-313-307-4176
Canine Flu Therapeutics Market Report
Global Canine Flu Therapeutics Market, Dynamics, Trends, Market Analysis
The Global Canine Flu Therapeutics Market is projected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of over xx% during the forecast period.
Wish to get a free sample report on this study? Click here.
Canine flu also referred to as dog flu, is a contagious disease that affects the dog’s respiratory system. It is primarily caused by the canine influenza virus or type A influenza virus. The flu consists of two types of influenza viruses H3N8 and the H3N2 virus. The symptoms of this disease include reduced appetite, upper respiratory illness, cough, eye discharges, runny nose, fever, and lethargy. The severity of the flu can range from dogs with no symptoms to terminal illness which can lead to pneumonia and finally death.
Key players operating in the global canine flu therapeutics market are-
Dogs are highly vulnerable to canine flu if they come in contact with the respiratory flow/discharges of the infected canines. As per the study by the Wisconsin University, the H3N2 virus retains its existence for a longer period of time when compared to the H3N8 virus, which leads to the spread of canine flu in other dogs resulting in multiple outbreaks. Dogs with canine flu cannot be easily identified, and so these dogs need protection. Moreover, there is no specific treatment for the disease thus stresses on the veterinary society to discover new drugs, which in turn augments the product demand.
By type, the canine flu therapeutics market has been segmented into vaccines, antibiotics, anti-inflammatory drugs, and others. Under these, the vaccines segment accounted for the largest market share in 2020 and is projected to register a healthy CAGR in the following years. Vaccination against canine flu influenza can significantly reduce the risk of the dog contracting the canine influenza virus, thus reduces the exposure, which bolsters the segment growth.
By region, the market in North America garnered the highest market share in 2020 and is projected to grow at a steady CAGR during the assessment period. This is mainly attributed to improvisation and development in the sex toys and condoms, rising LGBTQ+ population, increasing awareness of STDs and HIV infections, and increasing liberalization and experimentation of sexuality among the people, which further augments the regional growth.
North America dominant in the Global canine flu therapeutic market mainly due to the high penetration. In North America, particularly the USA is dominating due to the high adoption of treatment method to the canine flu.
The COVID-19 pandemic has positively influenced the Canine Flu Therapeutics industry. Condoms have experienced a surge, whereas the demand for sex toys and other items witnessed a temporary decline. However, to attend to their sexual needs due to the limited movement of people with partners staying in different homes, people have started relying on vibrators and other sex toys to cater to their sexual pleasure. Governments around the world have issued advisories to encourage safe sex with partners during the lockdown.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
Merck Animal Health (The US), GlaxoSmithKline (UK), Pfizer (The U.S), Zoetis (The U.S), Novartis (Switzerland), Sanofi (France), Boehringer Ingelheim International (Germany), Bristol-Myers Squibb (The U.S), Roche (Switzerland), Eli Lilly and Company (The U.S) and Abbott Laboratories (The U.S) are among the key players in the canine flu therapeutics market.
North America garnered the highest market share in 2020 and is projected to grow at a steady CAGR.
The vaccines segment accounted for the largest market share in 2020 and is projected to register a healthy CAGR.
Canine Flu Therapeutics companies, Canine Flu Therapeutics vendors, Condom companies, STD awareness organizations, LGBTQ communities are the target audience in the canine flu therapeutics market.
WE ACCEPT
